Health products' and substance use among pregnant women visiting a tertiary hospital in Belgium: A cross-sectional study.
Acetaminophen
/ administration & dosage
Adolescent
Adult
Alcohol Drinking
/ epidemiology
Belgium
/ epidemiology
Counselors
/ organization & administration
Cross-Sectional Studies
Female
Folic Acid
/ administration & dosage
Health Knowledge, Attitudes, Practice
Humans
Maternal Health
/ statistics & numerical data
Middle Aged
Preconception Care
/ statistics & numerical data
Pregnancy
Prevalence
Quality Improvement
Smoking
/ epidemiology
Tertiary Care Centers
/ organization & administration
Thyroxine
/ administration & dosage
Vitamins
/ administration & dosage
Young Adult
Belgium
drug utilization
folic acid
pharmacoepidemiology
preconception care
pregnancy
Journal
Pharmacoepidemiology and drug safety
ISSN: 1099-1557
Titre abrégé: Pharmacoepidemiol Drug Saf
Pays: England
ID NLM: 9208369
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
16
11
2018
revised:
07
05
2019
accepted:
27
06
2019
pubmed:
26
7
2019
medline:
9
6
2020
entrez:
26
7
2019
Statut:
ppublish
Résumé
To investigate the prevalence and type of health products used among pregnant women visiting a tertiary hospital in Belgium, as well as who advises these products, where women buy these products, which determinants are associated with medication and pregnancy vitamin intake, and preconception lifestyle changes such as folic acid intake and substance use. A cross-sectional study was performed at the outpatient obstetrics clinics of the University Hospital Leuven, Belgium between November 2016 and March 2017. All pregnant women 18 years and older and understanding Dutch, French, or English were asked to participate in an online survey. In total, 379 pregnant women participated. Prevalence of medication use during the preceding week was 52%. Paracetamol (14%), levothyroxine (13%), and antacids (9%) were the most frequently used medicines. Pregnancy vitamins were used by 86% of women, and 97% had used a pregnancy vitamin somewhere during pregnancy. Only 56% initiated folic acid supplementation at least 1 month before pregnancy. Preconception use of folic acid among women following assisted reproductive technology was 73%. Inappropriate use of health products was observed among 3% of women. Prevalence of alcohol use and/or smoking during the preceding week was 6%. Alcohol and smoking cessation mainly occurred after pregnancy diagnosis. Pregnant women living in Belgium frequently use medicines, pregnancy vitamins, and other health products. Preconception lifestyle changes such as folic acid intake and alcohol and smoking cessation are poorly implemented. Public campaigns and interventions are needed to improve preconception care and counselling.
Substances chimiques
Vitamins
0
Acetaminophen
362O9ITL9D
Folic Acid
935E97BOY8
Thyroxine
Q51BO43MG4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1231-1238Informations de copyright
© 2019 John Wiley & Sons, Ltd.
Références
Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19(4):408-417.
Ayad M, Costantine MM. Epidemiology of medications use in pregnancy. Semin Perinatol. 2015;39(7):508-511.
Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20(9):895-902.
Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193(3):771-777.
Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207-214.
Lupattelli A, Spigset O, Twigg MJ, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2):e004365. https://doi.org/10.1136/bmjopen-2013-004365
Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernandez-Diaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011;205(1):51.e1-51.e8.
Widnes SF, Schjott J. Risk perception regarding drug use in pregnancy. Am J Obstet Gynecol. 2017;216(4):375-378.
Lagan BM, Dolk H, White B, Uges DR, Sinclair M. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies. Pharmacoepidemiol Drug Saf. 2014;23(4):411-418.
Orizio G, Merla A, Schulz PJ, Gelatti U. Quality of online pharmacies and websites selling prescription drugs: a systematic review. J Med Internet Res. 2011;13(3):e74.
Beyene KA, Sheridan J, Aspden T. Prescription medication sharing: a systematic review of the literature. Am J Public Health. 2014;104(4):e15-e26.
Petersen EE, Rasmussen SA, Daniel KL, Yazdy MM, Honein MA. Prescription medication borrowing and sharing among women of reproductive age. J Womens Health. 2008;17(7):1073-1080.
Hall HG, Griffiths DL, McKenna LG. The use of complementary and alternative medicine by pregnant women: a literature review. Midwifery. 2011;27(6):817-824.
Kennedy DA, Lupattelli A, Koren G, Nordeng H. Herbal medicine use in pregnancy: results of a multinational study. BMC Complement Altern Med. 2013;13(1):355.
Bercaw J, Maheshwari B, Sangi-Haghpeykar H. The use during pregnancy of prescription, over-the-counter, and alternative medications among Hispanic women. Birth. 2010;37(3):211-218.
O'Leary CM. Fetal alcohol syndrome: diagnosis, epidemiology, and developmental outcomes. J Paediatr Child Health. 2004;40(1-2):2-7.
May PA, Chambers CD, Kalberg WO, et al. Prevalence of fetal alcohol spectrum disorders in 4 US communities. JAMA. 2018;319(5):474-482.
Chasnoff IJ, Wells AM, King L. Misdiagnosis and missed diagnoses in foster and adopted children with prenatal alcohol exposure. Pediatrics. 2015;135(2):264-270.
Muggli E, Matthews H, Penington A, et al. Association between prenatal alcohol exposure and craniofacial shape of children at 12 months of age. JAMA Pediatr. 2017;171(8):771-780.
De Santis M, Quattrocchi T, Mappa I, et al. Folic acid use in planned pregnancy: an Italian survey. Matern Child Health J. 2013;17(4):661-666.
Timmermans S, Jaddoe VW, Mackenbach JP, Hofman A, Steegers-Theunissen RP, Steegers EA. Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in The Netherlands: the Generation R study. Prev Med. 2008;47(4):427-432.
Van Calsteren K, Gersak K, Sundseth H, et al. Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for action. Eur J Obstet Gynecol Reprod Biol. 2016;201:211-214.
World Health Organization. Anatomical therapeutic chemical classification system. 2018.
Gagne JJ, Maio V, Berghella V, Louis DZ, Gonnella JS. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol. 2008;64(11):1125-1132.
Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clin Ther. 2012;34(1):239-49.e2.
Vandevijvere S, Amsalkhir S, Van Oyen H, Moreno-Reyes R. High prevalence of vitamin D deficiency in pregnant women: a national cross-sectional survey. PLoS ONE. 2012;7(8):e43868.
Hoppenbrouwers KRM, Guerin C, Van Leeuwen K, Desoete A Roelants M. Preventie van spina bifida en andere neuralebuisdefecten door foliumzuursuppletie tijdens de zwangerschap. Huidige praktijk in Vlaanderen en beleidsaanbevelingen. SWVG Feiten en Cijfers; 2010.
Delbaere I, Mokangi P, Roelens K, et al. Systematic development of an evidence-based website on preconception care. Ups J Med Sci. 2016;121:1-7.
Amitai Y, Koren G. Folic acid to prevent neural tube defects: another solution. BMJ. 2016;352:i763.
Vanham D, Spinewine A. Evaluation of the quality of counseling provided by community pharmacists to pregnant women. J Pharm Belg. 2010;13(3):68-74.
Mardby AC, Lupattelli A, Hensing G, Nordeng H. Consumption of alcohol during pregnancy-A multinational European study. Women Birth. 2017;30(4):e207-e213.
Skagerstrom J, Alehagen S, Haggstrom-Nordin E, Arestedt K, Nilsen P. Prevalence of alcohol use before and during pregnancy and predictors of drinking during pregnancy: a cross sectional study in Sweden. BMC Public Health. 2013;13(1):780.
Smedberg J, Lupattelli A, Mardby AC, Nordeng H. Characteristics of women who continue smoking during pregnancy: a cross-sectional study of pregnant women and new mothers in 15 European countries. BMC Pregnancy Childbirth. 2014;14(1):213.
Tsakiridis I, Mamopoulos A, Papazisis G, et al. Prevalence of smoking during pregnancy and associated risk factors: a cross-sectional study in Northern Greece. Eur J Public Health. 2018;28(2):321-325.
Schultze A, Kurz H, Stumpflen I, Hafner E. Smoking prevalence among pregnant women from 2007 to 2012 at a tertiary-care hospital. Eur J Pediatr. 2016;175(6):833-840.
Goossens J, Beeckman D, Van Hecke A, Delbaere I, Verhaeghe S. Preconception lifestyle changes in women with planned pregnancies. Midwifery. 2018;56:112-120.
Backhausen MG, Ekstrand M, Tyden T, et al. Pregnancy planning and lifestyle prior to conception and during early pregnancy among Danish women. Eur J Contracept Reprod Health Care. 2014;19(1):57-65.
O'Keeffe LM, Dahly DL, Murphy M, et al. Positive lifestyle changes around the time of pregnancy: a cross-sectional study. BMJ Open. 2016;6(5):e010233.
Goossens J, Delbaere I, Dhaenens C, et al. Preconception-related needs of reproductive-aged women. Midwifery. 2016;33:64-72.
Devlieger R, Martens E, Martens G, Van Mol C, Cammu H. Perinatal activities in Flanders, Belgium 2016. Study Centre for Perinatal Epidemiology. 2017.
Child and Family. The child in Flanders, Belgium 2016. https://www.kindengezin.be/img/kiv2016.pdf. 2017. Accessed 22.04.2019.
Statbel. Education and employment in Flanders, Belgium (2016). https://statbel.fgov.be/en. 2017. Accessed 22.04.2019.
Ceulemans M, Van Calsteren K, Allegaert K, Foulon V. Beliefs about medicines and information needs among pregnant women visiting a tertiary hospital in Belgium. Eur J Clin Pharmacol. 2019;75(7):995-1003.